Gilead Sciences (GILD) just cleared an important milestone: its once daily bictegravir and lenacapavir combo matched Biktarvy in the Phase 3 ARTISTRY 2 trial, with clean safety data that strengthens ...

Wondering if Gilead Sciences is still a smart buy after its big run, or if the stock has already priced in the good news? Here is a breakdown of whether the current share price really lines up with ...

So far five companies have agreed to the terms. They are Pfizer, Eli ​Lilly, AstraZeneca, Novo Nordisk and EMD Serono, which ...

While autologous therapies are mainstream in blood cancers, experts warn against overhyping allogeneic and in vivo approaches ...

Gilead Sciences (NASDAQ: GILD) has outperformed the market over the past 20 years by 2.66% on an annualized basis producing an average annual return of 11.48%. Currently, Gilead Sciences has a market ...

The annual Morrow County Chamber of Commerce Parade was held Dec. 5 in Mount Gilead. As for the floats in this year’s parade, ...

Private George S. Bowden, son of Mr. and Mrs. Sumler Bowden, Jr. of Mt. Gilead, recently completed basic training at Fort Knox, Ky. During the training, students received instruction in drill and ...

Gilead has shown its ambition in oncology by poaching Novartis' Alessandro Riva to progress its cancer portfolio. Riva is currently head of global oncology development at Novartis, where he has led ...

An Ohio medical specialty camp providing experiences at no cost for kids with serious illnesses is celebrating a major ...

Compounding that statistic, prior studies indicate some trans people at high risk for HIV transmission are hesitant to take ...

The series is set within the same universe as The Handmaid's Tale; however will focus on new characters as well as some ...

The FDA contacted J&J right after ASH to discuss using a special fast pass on a multiple myeloma regimen. Elsewhere, a new ...